Generate Over 500 Local Jobs
Hyderabad, February 20:
Gland Pharma has announced an investment of over Rs. 400 crores in Genome Valley. The new facility, focused on advanced areas such as Biologicals, Biosimilars, Antibodies, and Recombinant Insulin, has the potential to create over 500 employment opportunities for local youth.
The announcement was made after a meeting between the Industries Minister KTR and the MD and CEO of Gland Pharma, Srinivas Sadu, today. Present at the meeting were Jayesh Ranjan, Principal Secretary of Industries and Commerce Dept, and Shakthi Nagappan, CEO of Telangana Life Sciences.
Expressing his excitement about the new facility, KTR said, “This facility truly demonstrates the strength of the life sciences ecosystem in Hyderabad and Genome Valley.”
